php4 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Specificity

The PHP4 antibody is part of a panel (PHP1–4) designed to detect distinct conformational epitopes within the N-terminal region of mHTT, specifically targeting the proline-rich domain (PRD) and the boundary between polyglutamine (polyQ) and polyproline (polyP) repeats .

  • Epitope: Recognizes a novel linear sequence (QQQQQQPP) at the polyQ/polyP boundary .

  • Isotype: IgG1κ .

  • Species reactivity: Human and murine HTT .

Key Findings from In Vitro Assays

Assay TypeReactivity of PHP4 AntibodyReference
Dot blotWeak binding to monomeric mHTT and fibrils; stronger binding to soluble aggregates .
Peptide arrayBinds to polyQ/polyP boundary; proline residues critical for interaction .
SMC Errena immunoassayDetects early-stage mHTT aggregates (within 30 min of MBP cleavage) .
  • PHP4’s epitope accessibility depends on mHTT conformation, showing limited reactivity to fully formed fibrils but stronger binding to soluble oligomers .

  • Mutagenesis of the PRD (e.g., replacing native residues with polyP) abolishes PHP4 binding, confirming specificity for the native Q/P-rich sequence .

Comparative Analysis with PHP Antibodies

AntibodyEpitopeReactivity ProfileKey Application
PHP1QAQPLLPQP (PRD)High affinity for unbundled fibrils .Detecting early fibril intermediates .
PHP2QAQPLLPQP (PRD)Similar to PHP1 but lower potency .Structural studies of PRD .
PHP3QQQQQQPP (polyQ/polyP)Weak binding to fibrils .Mapping polyQ/polyP interactions .
PHP4QQQQQQPP (polyQ/polyP)Prefers soluble aggregates over fibrils .Studying oligomerization dynamics .

Research Implications

  • Pathogenic Insights: PHP4 helps distinguish between toxic oligomers and mature fibrils, aiding in understanding HD progression .

  • Therapeutic Development: Identifies conformational changes in mHTT, enabling targeted drug screening for aggregation inhibitors .

  • Diagnostic Potential: May serve as a biomarker for early-stage HD by detecting soluble aggregates in biofluids .

Limitations and Future Directions

  • Low Accessibility: PHP4’s epitope is often buried in fibrillar structures, limiting utility in late-stage HD models .

  • Co-factor Requirements: Binding efficiency may depend on post-translational modifications or partner proteins not yet characterized .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
php4 antibody; SPBC16E9.01c antibody; SPBP16F5.09c antibody; CCAAT-binding factor complex subunit php4 antibody
Target Names
php4
Uniprot No.

Target Background

Function
Php4 antibody is a component of the transcription regulatory CCAAT-binding complex. It plays a crucial role in reprogramming the cell for iron utilization. Under low-iron conditions, Php4 downregulates the expression of pcl1, sdh4, and isa1 genes.
Gene References Into Functions
  1. A study aimed to biochemically define the protein-protein and protein-metal interactions. It was found that Grx4 binds a [2Fe-2S] cluster with spectroscopic features similar to other CGFS glutaredoxins. Grx4 and Php4 were also found to copurify as a complex with a [2Fe-2S] cluster, spectroscopically distinct from the cluster on Grx4. These results demonstrate that Grx4 regulates Php4 function through binding of a bridging [2Fe-2S] cluster. PMID: 28725905
  2. Grx4 independently governs the Php4 and Fep1 repressors through metal transfer. The total or partial disassembly of the Grx4-Fra2 cluster actively participates in the iron-containing Fep1 activation. PMID: 25806539
  3. Grx4 and Crm1 are novel components involved in the mechanism by which Php4 is inactivated by iron in a Fep1-independent manner. PMID: 19502236
Database Links
Subcellular Location
Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, spindle pole.

Q&A

What is Php4 and what role does it play in iron regulation?

Php4 is a transcriptional regulator involved in iron homeostasis. It functions primarily by repressing iron-using genes under low-iron conditions to conserve cellular iron resources. When iron is abundant, Php4 is inactivated through a mechanism involving both protein relocalization and functional inhibition. Specifically, under iron-replete conditions, Php4 is exported from the nucleus to the cytoplasm, preventing it from repressing its target genes. This export is mediated by a leucine-rich nuclear export signal (NES) located within amino acids 93-100 of the Php4 protein .

The regulation of Php4 involves several key proteins, including Grx4 (glutaredoxin-4) and Crm1 (a nuclear export receptor). These proteins physically interact with Php4 and are essential components in the iron-sensing mechanism. Deletion of the grx4 gene results in constitutive activity of Php4 and its invariable nuclear localization, highlighting the crucial role of Grx4 in Php4 regulation .

What experimental approaches can be used to detect and visualize Php4 protein in cells?

Several experimental strategies have proven effective for Php4 detection and visualization:

GFP Fusion Proteins:
GFP-Php4 fusion constructs allow real-time tracking of Php4 localization in living cells. The construct can be placed under a constitutive GATA-less php4+ promoter to ensure that any effects of iron on GFP-Php4 are independent of changes in gene expression .

Immunofluorescence:
Similar to approaches used for other antibody targets, Php4 can be visualized using specific antibodies followed by fluorescently-labeled secondary antibodies. This method requires careful fixation and permeabilization protocols to preserve cellular architecture while allowing antibody access.

Bimolecular Fluorescence Complementation (BiFC):
This technique has been successfully employed to study Php4 interactions with partner proteins such as Grx4. BiFC allows visualization of protein-protein interactions in living cells by bringing together two non-fluorescent fragments of a fluorescent protein when the proteins of interest interact .

How do iron levels affect Php4 subcellular localization and function?

Iron levels have profound effects on both Php4 localization and function:

Iron ConditionPhp4 LocalizationPhp4 FunctionDownstream Effect
Low ironNuclearActiveRepression of iron-using genes
High ironCytoplasmicInactiveDerepression of iron-using genes

Under low iron conditions, GFP-Php4 accumulates in the nucleus where it actively represses target genes like isa1+. When iron is added to the growth medium, GFP-Php4 is exported to the cytoplasm within approximately 60 minutes. This nuclear export is mediated by the Crm1 exportin and can be blocked by leptomycin B (LMB), an inhibitor of Crm1-dependent nuclear export .

Importantly, even when Php4 is retained in the nucleus (such as in the presence of LMB), the protein can still be inactivated by iron, resulting in derepression of target genes. This indicates that iron regulates Php4 through dual mechanisms: subcellular relocalization and functional inactivation .

What methods can be used to validate the specificity of a Php4 antibody?

Validating antibody specificity is critical for reliable research outcomes. For Php4 antibodies, consider these validation approaches:

Genetic Knockout Controls:
Testing the antibody in php4-knockout cells is the gold standard for validation. A specific antibody should show no signal in knockout samples while detecting Php4 in wild-type samples .

Recombinant Protein Controls:
Using purified recombinant Php4 protein at known concentrations can help establish detection sensitivity and specificity thresholds for the antibody .

Multiple Antibody Comparison:
Using multiple antibodies targeting different epitopes of Php4 can increase confidence in specificity. Consistent results across different antibodies suggest target-specific detection .

Application-Specific Validation:
Antibodies must be validated specifically for each application (Western blot, immunoprecipitation, immunofluorescence) as performance can vary significantly between applications .

Recent initiatives by organizations like YCharOS have demonstrated that recombinant antibodies generally show higher specificity and reproducibility compared to polyclonal antibodies , suggesting researchers should prioritize well-characterized recombinant antibodies when available.

How can researchers distinguish between direct Php4 regulation and secondary effects in gene expression studies?

Distinguishing between direct and indirect Php4 effects requires sophisticated experimental approaches:

Chromatin Immunoprecipitation (ChIP):
ChIP using Php4 antibodies can identify direct DNA binding sites. This approach identifies genomic loci where Php4 physically interacts with DNA, thus identifying direct regulatory targets. The technique can be combined with sequencing (ChIP-seq) for genome-wide identification of Php4 binding sites.

Rapid Perturbation Systems:
Using systems that allow rapid nuclear import/export or activation/inactivation of Php4 (such as a rapamycin-induced dimerization system) can help distinguish immediate direct effects from secondary regulatory cascades by analyzing temporal gene expression changes.

Mutational Analysis:
Creating mutations in the DNA-binding domain of Php4 that maintain protein stability but eliminate DNA binding can help differentiate between effects requiring direct DNA binding and those mediated by protein-protein interactions.

Integrative Analysis:
Combining transcriptomics with Php4 ChIP-seq data and protein interaction studies provides a comprehensive view of the regulatory network. Genes showing both Php4 binding and expression changes are likely direct targets, while those showing expression changes without binding evidence may represent secondary effects.

What are the methodological considerations for studying Php4-Grx4 interactions using antibody-based approaches?

Studying the critical Php4-Grx4 interaction requires careful experimental design:

Co-immunoprecipitation (Co-IP):
Co-IP experiments have successfully demonstrated physical interaction between Php4 and Grx4. For optimal results, consider:

  • Using TAP-tagged Php4 constructs to facilitate efficient pulldown

  • Including proper controls for antibody specificity and background binding

  • Testing interaction under both low and high iron conditions to capture iron-dependent changes

  • Validating results with reciprocal pulldowns (using Php4 to pull down Grx4 and vice versa)

Proximity Ligation Assay (PLA):
PLA offers a sensitive method to detect protein-protein interactions in situ. This technique uses pairs of antibodies against Php4 and Grx4, each conjugated to different oligonucleotides that, when in close proximity, allow rolling circle amplification and fluorescent detection.

BiFC and Two-Hybrid Systems:
Bimolecular fluorescence complementation assays and two-hybrid assays have already been successfully employed to demonstrate Php4-Grx4 interaction in vivo . These approaches can be extended to characterize domains involved in the interaction by testing truncated or mutated proteins.

Structural Studies:
Advanced structural analysis using techniques like X-ray crystallography or cryo-electron microscopy can elucidate the molecular basis of the interaction, though these approaches typically require large amounts of purified proteins and may involve antibody fragments to facilitate crystallization.

How can researchers optimize immunoprecipitation protocols specifically for Php4 complexes?

Immunoprecipitation of Php4 requires careful optimization to maintain physiologically relevant interactions:

Buffer Composition Considerations:

  • Salt concentration: Typically 150 mM NaCl works well for most proteins, but higher concentrations (300-500 mM) may reduce non-specific binding. Testing a salt gradient can identify optimal conditions.

  • Detergent selection: Mild non-ionic detergents (0.1-0.5% NP-40 or Triton X-100) generally preserve protein-protein interactions. For membrane-associated complexes, digitonin may better preserve native complexes.

  • Divalent cations: Include MgCl₂ (1-5 mM) if studying DNA-bound Php4.

  • Iron chelators or supplements: Consider how buffer composition might affect iron-dependent interactions.

Crosslinking Options:
Formaldehyde (1% for 10 minutes) or other crosslinkers can capture transient interactions but may introduce artifacts. Perform parallel experiments with and without crosslinking for comprehensive analysis.

Elution Strategies:

  • Competitive elution with epitope peptides for tagged Php4

  • Acid elution (pH 2.5-3.0 glycine buffer)

  • SDS elution (more denaturing, disrupts antibody binding)

Validation Approaches:

  • Mass spectrometry analysis of immunoprecipitated complexes

  • Western blotting for known interaction partners

  • Size exclusion chromatography to verify native complex size

What approaches can best characterize the iron-dependent inactivation mechanism of Php4?

Understanding the molecular details of iron-dependent Php4 inactivation requires a multi-faceted approach:

Mutagenesis Studies:
Systematic mutagenesis of potential iron-sensing residues in Php4 and Grx4 can identify critical amino acids involved in the regulatory mechanism. Key experiments should include:

  • Alanine scanning of conserved cysteine and histidine residues that might coordinate iron

  • Creation of phosphomimetic mutations to assess potential roles of phosphorylation

  • Domain swapping between Php4 and non-iron-regulated transcription factors

Real-time Protein Modification Analysis:
Mass spectrometry approaches like hydrogen-deuterium exchange mass spectrometry (HDX-MS) can detect conformational changes in Php4 upon iron binding or Grx4 interaction. Additionally, protein electrophoresis under non-reducing conditions might reveal iron-dependent disulfide formation.

In Vitro Reconstitution:
Purified recombinant Php4, Grx4, and iron can be combined in vitro to study direct effects and requirements for additional cofactors. This approach allows precise control of reaction conditions and component concentrations.

Structural Biology Approaches:
X-ray crystallography, NMR, or cryo-EM structures of Php4 in both active and inactive states could provide definitive mechanistic insights, though these techniques present significant technical challenges.

How can researchers design antibodies with enhanced specificity for Php4 over related transcription factors?

Designing highly specific Php4 antibodies requires strategic approaches:

Epitope Selection Strategy:
Target unique regions of Php4 that lack homology with related proteins. The optimal approach involves:

  • Performing multiple sequence alignment of Php4 with related transcription factors

  • Identifying regions with minimal sequence conservation

  • Analyzing these regions for surface accessibility and immunogenicity

  • Prioritizing disordered regions that are typically more accessible to antibodies

Advanced Antibody Engineering Techniques:
Recent computational models can guide antibody design beyond traditional selection methods. Biophysics-informed models trained on phage display data can predict antibody-epitope interactions and guide the development of variants with customized specificity profiles . This approach allows for:

  • Disentangling multiple potential binding modes

  • Designing antibodies that are highly specific for Php4

  • Creating cross-reactive antibodies when appropriate (e.g., for detecting Php4 across species)

Validation Requirements:
For newly developed Php4 antibodies, comprehensive validation must include:

  • Testing against wild-type and php4-knockout cells

  • Cross-reactivity assessment against related transcription factors

  • Application-specific validation (Western blot, IP, IF)

  • Batch-to-batch consistency verification

Validation MethodControls RequiredExpected OutcomePotential Pitfalls
Western blotWT and php4-KO lysatesSingle band at correct MW in WT, absent in KONon-specific bands, particularly in nuclear extracts
ImmunofluorescenceWT and php4-KO cells, subcellular markersNuclear signal in low iron, cytoplasmic in high ironBackground staining, fixation artifacts
ChIPInput controls, IgG controls, php4-KO cellsEnrichment at known target genesNon-specific chromatin binding
IP-Mass SpecIgG controls, competing peptideEnrichment of known interactors (Grx4)Contamination with abundant proteins

What are the optimal fixation and permeabilization protocols for Php4 immunofluorescence studies?

Successful immunofluorescence detection of Php4 requires careful consideration of fixation and permeabilization methods:

Fixation Options:

Permeabilization Considerations:

  • Triton X-100 (0.1-0.5%, 5-10 minutes): Standard permeabilization agent that provides good antibody access to nuclear proteins.

  • Saponin (0.1%, 10 minutes): Milder detergent that may preserve certain epitopes better than Triton.

  • Digitonin (10-50 μg/ml): Selectively permeabilizes the plasma membrane while leaving nuclear membranes intact, useful for distinguishing cytoplasmic from nuclear Php4.

Protocol Optimization:

  • Test multiple fixation/permeabilization combinations with your specific antibody

  • Include control experiments with GFP-Php4 to confirm pattern validity

  • Consider antigen retrieval methods if initial results are suboptimal

  • Optimize blocking conditions to minimize background (5% BSA or normal serum from secondary antibody host species)

What controls are essential for interpreting Php4 antibody-based experiments?

Rigorous experimental controls are crucial for reliable interpretation of Php4 antibody experiments:

Genetic Controls:

  • Knockout/knockdown samples: Cells lacking Php4 provide the gold standard negative control

  • Overexpression samples: Cells overexpressing Php4 serve as positive controls

  • Tagged Php4 constructs: Can be detected with both Php4 antibodies and tag-specific antibodies

Biological Condition Controls:

  • Iron treatment: Testing under both low and high iron conditions provides internal verification of expected Php4 behavior

  • Leptomycin B treatment: Blocks nuclear export and can help distinguish localization from functional effects

Technical Controls:

  • Secondary antibody only: Controls for non-specific secondary antibody binding

  • Isotype control antibodies: Controls for non-specific primary antibody binding

  • Blocking peptide competition: Pre-incubation with immunizing peptide should abolish specific signal

Reproducibility Controls:

  • Testing multiple antibody lots

  • Using multiple antibodies targeting different Php4 epitopes

  • Independent replication by different researchers

How can researchers troubleshoot non-specific binding issues with Php4 antibodies?

Non-specific binding is a common challenge that requires systematic troubleshooting:

Common Sources of Non-specific Binding:

  • Cross-reactive proteins: Proteins sharing epitope similarity with Php4

  • Fc receptor binding: Particularly in immune cells that express Fc receptors

  • Hydrophobic interactions: Non-specific binding to hydrophobic protein regions

  • Denatured protein aggregates: May create artificial epitopes

Optimization Strategies:

  • Blocking optimization: Test different blocking agents (BSA, milk, normal serum, commercial blockers)

  • Antibody concentration titration: Determine optimal concentration that maximizes signal-to-noise ratio

  • Buffer optimization: Adjust salt concentration (100-500 mM) and detergent type/concentration

  • Pre-adsorption: Pre-incubate antibody with php4-knockout lysate to remove cross-reactive antibodies

Advanced Solutions:

  • Affinity purification: Purify antibodies against recombinant Php4 protein

  • Subtraction strategy: For polyclonal antibodies, remove cross-reactive antibodies using knockout cell lysates

  • Switch to recombinant antibodies: Consider monoclonal or recombinant antibodies with defined specificity

  • Epitope tagging: If persistent problems occur, consider using epitope-tagged Php4 with highly specific commercial tag antibodies

What are the best practices for quantifying Php4 levels in different cellular compartments?

Accurate quantification of Php4 in different cellular compartments requires careful methodological considerations:

Subcellular Fractionation Approaches:

  • Standard nuclear/cytoplasmic fractionation using NP-40 lysis followed by nuclear extraction

  • More detailed fractionation to separate nucleoplasm from chromatin-bound fractions

  • Quality control of fractions using compartment-specific markers (HDAC1 for nucleus, α-tubulin for cytoplasm)

Immunofluorescence Quantification Methods:

  • Measure nuclear/cytoplasmic intensity ratio rather than absolute values

  • Use automated image analysis software with nuclear and cytoplasmic masks

  • Analyze sufficient cell numbers (>100) to account for cell-to-cell variability

  • Employ Z-stack imaging to capture the full nuclear volume

Western Blot Quantification:

  • Use loading controls specific to each cellular compartment

  • Employ standard curves with recombinant Php4 for absolute quantification

  • Validate linear range of detection for accurate comparative analysis

  • Consider using fluorescent secondary antibodies for wider linear range

Live Cell Imaging Considerations:
For GFP-Php4 experiments:

  • Correct for photobleaching and background

  • Use nuclear and cytoplasmic regions of interest (ROIs) for ratiometric analysis

  • Consider FRAP (Fluorescence Recovery After Photobleaching) to assess mobility

How might single-cell analysis techniques advance our understanding of Php4 regulation?

Single-cell techniques offer new insights into cell-to-cell heterogeneity in Php4 regulation:

Single-Cell Imaging Applications:
High-content imaging of GFP-Php4 can reveal population heterogeneity in nuclear/cytoplasmic distribution. This approach can identify:

  • Subpopulations with distinct Php4 regulatory states

  • Correlation between Php4 localization and cell cycle phase

  • Dynamic responses to changing iron levels at single-cell resolution

Single-Cell Proteomics:
Emerging mass cytometry (CyTOF) or microfluidic techniques could quantify Php4 levels and modification states in individual cells when coupled with well-validated antibodies.

Single-Cell Multi-omics Integration:
Combining single-cell transcriptomics with protein measurements could reveal relationships between Php4 localization/activity and target gene expression at individual cell resolution.

Theoretical Modeling:
Computational models incorporating single-cell data could predict:

  • How noise in iron sensing affects Php4 regulation

  • Whether Php4 regulation exhibits bistability or graded responses

  • How cell-to-cell variability affects population-level iron homeostasis

What are the potential applications of Php4 antibodies in studying disease models?

While Php4 has been primarily studied in model organisms like yeast, antibodies against related proteins in disease models offer significant research potential:

Cancer Research Applications:
Iron metabolism is often dysregulated in cancer cells. Php4-related transcription factors may play roles in:

  • Adapting to iron limitation in the tumor microenvironment

  • Regulating genes involved in metastasis and invasion

  • Mediating responses to iron-targeting therapies

Neurodegenerative Disease Research:
Iron accumulation and dysregulated iron metabolism are implicated in conditions like Alzheimer's and Parkinson's diseases. Investigating Php4-related factors might provide insights into:

  • Mechanisms of iron accumulation in affected brain regions

  • Cellular responses to iron overload

  • Potential therapeutic targets for restoring iron homeostasis

Methodology Translation:
The approaches developed for Php4 antibody validation and application can serve as templates for studying iron regulatory proteins in disease models:

  • Application-specific validation strategies

  • Quantitative localization methods

  • Interaction partner identification techniques

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.